Surgery News and Research

RSS

Esaote introduces eXP technology-powered EVOLUTION’15 at ECR 2015

At ECR 2015 Esaote, a world leading manufacturer of medical diagnostic systems, introduces Evolution’15 (EVO’15) as the latest upgrade in its dedicated MRI Evolution program. EVO’15 combines software updates and new hardware features to provide superb image quality and increases productivity by almost 50%.

25 Feb 2015

Serous ovarian cancer is more deadly, shows Cancer Research UK study

THE most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells, according to a Cancer Research UK study published today (Tuesday) in PLOS Medicine.

25 Feb 2015

Johns Hopkins scientists identify genetic pathway that may spur cancer cell growth in children

Working with cells taken from children with a very rare but ferocious form of brain cancer, Johns Hopkins Kimmel Cancer Center scientists have identified a genetic pathway that acts as a master regulator of thousands of other genes and may spur cancer cell growth and resistance to anticancer treatment.

24 Feb 2015

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania's Abramson Cancer Center during the 2015 Genitourinary Cancers Symposium.

24 Feb 2015

Researchers find key protein critical to the success of common anti-platelet drug Plavix

Researchers at the UNC School of Medicine have found that the blood platelet protein Rasa3 is critical to the success of the common anti-platelet drug Plavix, which breaks up blood clots during heart attacks and other arterial diseases.

24 Feb 2015

Body hang-ups prevent UK women to have health checkup, finds new HeartAge research

New research revealed today by HeartAge has found that almost four million British women are putting their own health at risk, as they are too embarrassed to have a health check.

24 Feb 2015

Study results report no benefit from use of sunitinib, sorafenib among patients with kidney cancer

Research results highlighted today at the press conference of a major medical meeting report no benefit from the use of either Sutent (sunitinib) or Nexavar (sorafenib) among patients with locally advanced renal cell carcinoma at high risk of recurrence, the ECOG-ACRIN Cancer Research Group announced.

24 Feb 2015

IRIDEX to unveil Cyclo G6 laser system for treatment of glaucoma at AGS annual congress

IRIDEX Corporation today announced that it will debut Cyclo G6, the Company's first laser platform dedicated to the treatment of glaucoma, at this year's annual congress of the American Glaucoma Society.

23 Feb 2015

Johns Hopkins researcher helps discover effectiveness of three drugs for treating patients with DME

A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs -- Eylea, Avastin and Lucentis -- used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.

23 Feb 2015

Tillotts Pharma announces results of new survey in UC, introduces UCandME toolbox at ECCO 2015

Tillotts Pharma announced today results from a new European survey that revealed more than 9 out of 10 people with ulcerative colitis (UC) have low to medium adherence to their medication, putting them at five times greater risk of relapse.

23 Feb 2015

Smartphones, tablets can do damage to overall health in unexpected ways

Despite the many benefits of having information at your fingertips, smartphones and tablets can do damage to your body and overall health in unexpected ways.

21 Feb 2015

Rush University Medical Center earns three-star rating for lung cancer surgery program

Surgery to remove localized tumors is the only reliable way to cure lung cancer, the most prevalent cause of cancer-related deaths in both men and women. The most common operation performed to remove these cancers is a lobectomy (removal of an anatomic portion of lung). Thoracic surgeons at Rush University Medical Center perform the largest number of these operations of any surgical group in Chicago and in most cases use minimally invasive techniques that speed recovery.

21 Feb 2015

Research findings lay groundwork for improving treatment assessment for men with prostate cancer

UCLA researchers have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient prognosis. These findings lay the groundwork for improved treatment assessment by physicians and to better inform men fighting the disease.

20 Feb 2015

New planning tool helps identify patients' risks of chronic pain after surgery

There are many variables that contribute to a patient's risk of chronic pain after surgery; physicians are still exploring ways to identify those variables prior to surgery.

20 Feb 2015

Sensor technology has potential to improve teaching of proper CBE techniques

Sensor technology has the potential to significantly improve the teaching of proper technique for clinical breast exams (CBE), according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.

20 Feb 2015

Study compares two different methods of blood transfusion in trauma care

The University of Maryland School of Medicine is part of a new nationwide, multi-site study that may help save hundreds of lives among trauma patients with major bleeding. The study, which was published earlier this month in JAMA, compared two different methods of blood transfusion, and found that one approach gave patients a significantly better chance of survival within the first 24 hours.

20 Feb 2015

Study: Risk of uterine sarcoma fairly low in women following hysterectomy

Uterine sarcoma - a potentially aggressive type of cancer that forms in tissues in the uterus - was found in 0.22 % of women following a hysterectomy for benign conditions, a new large-scale study by the University of Michigan departments of Obstetrics and Gynecology, and Surgery finds.

20 Feb 2015

MIT chemical engineers develop new type of self-healing hydrogel

Scientists are interested in using gels to deliver drugs because they can be molded into specific shapes and designed to release their payload over a specified time period. However, current versions aren't always practical because must be implanted surgically.

20 Feb 2015

Study results pave way for new clinical trial for glioblastoma patients

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research.

19 Feb 2015

Geriatric consultation could improve care for elderly patients admitted for traumatic injuries

Elderly patients who are admitted to the hospital for monitoring and surgical treatment of traumatic injuries could have better geriatric care if medical teams took one extra step—offering geriatric consultation, according to new research findings from surgical and geriatric medicine teams at the Ronald Reagan University of California at Los Angeles Medical Center.

19 Feb 2015

Surgery News and Research

Esaote introduces eXP technology-powered EVOLUTION’15 at ECR 2015

Serous ovarian cancer is more deadly, shows Cancer Research UK study

Johns Hopkins scientists identify genetic pathway that may spur cancer cell growth in children

Two widely used targeted therapy drugs not effective in preventing return of kidney cancer

Researchers find key protein critical to the success of common anti-platelet drug Plavix

Body hang-ups prevent UK women to have health checkup, finds new HeartAge research

Study results report no benefit from use of sunitinib, sorafenib among patients with kidney cancer

IRIDEX to unveil Cyclo G6 laser system for treatment of glaucoma at AGS annual congress

Johns Hopkins researcher helps discover effectiveness of three drugs for treating patients with DME

Tillotts Pharma announces results of new survey in UC, introduces UCandME toolbox at ECCO 2015

Smartphones, tablets can do damage to overall health in unexpected ways

Rush University Medical Center earns three-star rating for lung cancer surgery program

Research findings lay groundwork for improving treatment assessment for men with prostate cancer

New planning tool helps identify patients' risks of chronic pain after surgery

Sensor technology has potential to improve teaching of proper CBE techniques

Study compares two different methods of blood transfusion in trauma care

Study: Risk of uterine sarcoma fairly low in women following hysterectomy

MIT chemical engineers develop new type of self-healing hydrogel

Study results pave way for new clinical trial for glioblastoma patients

Geriatric consultation could improve care for elderly patients admitted for traumatic injuries

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News